Duke Energy Corp vs Nuwellis Inc — how do they compare? Duke Energy Corp trades at $126.37 (market cap $98.52B), while Nuwellis Inc trades at $3.16 (market cap $1.17M). The key difference: Duke Energy Corp is far larger — about 84205.1× Nuwellis Inc's market cap, and Duke Energy Corp pays a 3.37% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| DUK | NUWE | |
|---|---|---|
Market Cap | $98.52B | $1.17M |
Sector | Utilities | Technology |
52-Week High | $133.46 | $558.26 |
52-Week Low | $113.99 | $2.80 |
Enterprise Value | $188.56B | -$636.97K |
Dividend Yield | 3.37% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $2.80, down 7.89% in the last session, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025 despite $8.27M revenue, reflecting negative profit margins and cash flow challenges. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026, alongside a CEO transition to Mike McCormick effective June 30, 2026.
Outlook remains high-risk due to persistent losses and cash burn, though analyst consensus is split evenly between Buy and Hold. Key risks include execution in revenue growth and reliance on financing. Upside depends on successful commercialization of Aquadex therapy and FDA label expansion for pediatric patients.
Trailing returns across standard periods
Latest headlines on both assets
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →